file:: [malaria_intensive_care_1718103987861_0.pdf](../assets/malaria_intensive_care_1718103987861_0.pdf)
file-path:: ../assets/malaria_intensive_care_1718103987861_0.pdf

- The signs requiring ICU management 
  ls-type:: annotation
  hl-page:: 2
  hl-color:: yellow
  id:: 66683016-0791-424c-9658-c686baa31deb
- 10–15 days after a bite by an infected mosquito
  ls-type:: annotation
  hl-page:: 2
  hl-color:: yellow
  id:: 666830a2-1dac-4f12-9055-03c9c59851c2
- acute febrile disease symptoms 
  ls-type:: annotation
  hl-page:: 2
  hl-color:: red
  id:: 666830aa-fc8b-4725-836a-85d33160da3e
- headaches in malaria may be severe but are not associated with the neck stiﬀness or photophobia that are common in bacterial meningitis
  ls-type:: annotation
  hl-page:: 3
  hl-color:: yellow
  id:: 666830ca-a902-4bf6-94f5-65fec4bc50be
- Uncomplicated malaria
  ls-type:: annotation
  hl-page:: 3
  hl-color:: yellow
  id:: 66683224-3aa6-4b07-89bd-649723b03e0a
- [:span]
  ls-type:: annotation
  hl-page:: 4
  hl-color:: yellow
  id:: 666832e4-7dff-4c8a-8ae5-29b38057c7d8
  hl-type:: area
  hl-stamp:: 1718104802901
- speciﬁc antimalarial treatment and supportive care provided to address physiologic dysfunction resulting from the presence of malaria parasites. 
  ls-type:: annotation
  hl-page:: 6
  hl-color:: yellow
  id:: 666833e9-4dfa-4111-b5ea-2d82b248be80
- The current recommendation is individualized conservative ﬂuid management for patients with severe malaria
  ls-type:: annotation
  hl-page:: 6
  hl-color:: yellow
  id:: 66683407-33cb-4ce8-8ea8-de0d8f0cbb63
- Severe malaria requires prompt parenteral antimalarial treatment once a diagnosis has been made. 
  ls-type:: annotation
  hl-page:: 7
  hl-color:: yellow
  id:: 6668345a-b77a-408c-b04a-b39f7f9aebf4
- Artesunate
  ls-type:: annotation
  hl-page:: 7
  hl-color:: red
  id:: 6668348b-ea70-430f-b529-399d4d2ad79d
- Summary of treatment options for severe malaria
  ls-type:: annotation
  hl-page:: 5
  hl-color:: yellow
  id:: 66683512-9c28-4367-bac1-796145e489e3
- [:span]
  ls-type:: annotation
  hl-page:: 5
  hl-color:: yellow
  id:: 66683536-3d5e-4b3f-b447-72f8b5c12d58
  hl-type:: area
  hl-stamp:: 1718105395469
- Oral and parenteral forms of quinine as sulfate and dihydrochloride salts, respectively, are commonly used in clinical practice
  ls-type:: annotation
  hl-page:: 5
  hl-color:: yellow
  id:: 6668364b-def5-4f85-819b-76e2d321b80d